Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients
- 1 January 2008
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 12 (1) , 51-56
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Prevalence of Hepatitis C, HIV, and Risk Behaviors for Blood-Borne Infections: A Population-Based Survey of the Adult Population of T'bilisi, Republic of GeorgiaJournal of Urban Health, 2006
- Hepatotoxicity of antiretrovirals: Incidence, mechanisms and managementJournal of Hepatology, 2006
- Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infectionCurrent Medical Research and Opinion, 2005
- Monitoring and management of antituberculosis drug induced hepatotoxicityJournal of Gastroenterology and Hepatology, 2005
- High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis: Table. 1—European Respiratory Journal, 2005
- Hepatotoxicity of Rifampin and Pyrazinamide in the Treatment of Latent Tuberculosis Infection in HIV-Infected Persons: Is It Different Than in HIV-Uninfected Persons?Clinical Infectious Diseases, 2004
- Hepatotoxicity of Rifampin-Pyrazinamide and Isoniazid Preventive Therapy and Tuberculosis TreatmentClinical Infectious Diseases, 2004
- Severe Hepatotoxicity Associated with Rifampin-Pyrazinamide Preventative Therapy Requiring Transplantation in an Individual at Low Risk for HepatotoxicityClinical Infectious Diseases, 2003
- Isoniazid Hepatotoxicity among Drug Users: The Role of Hepatitis CClinical Infectious Diseases, 2003
- Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected withMycobacterium tuberculosisClinical Infectious Diseases, 2001